677 related articles for article (PubMed ID: 23213075)
1. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
Bañares R; Nevens F; Larsen FS; Jalan R; Albillos A; Dollinger M; Saliba F; Sauerbruch T; Klammt S; Ockenga J; Pares A; Wendon J; Brünnler T; Kramer L; Mathurin P; de la Mata M; Gasbarrini A; Müllhaupt B; Wilmer A; Laleman W; Eefsen M; Sen S; Zipprich A; Tenorio T; Pavesi M; Schmidt HH; Mitzner S; Williams R; Arroyo V;
Hepatology; 2013 Mar; 57(3):1153-62. PubMed ID: 23213075
[TBL] [Abstract][Full Text] [Related]
2. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation.
Lexmond WS; Van Dael CM; Scheenstra R; Goorhuis JF; Sieders E; Verkade HJ; Van Rheenen PF; Kömhoff M
Liver Transpl; 2015 Mar; 21(3):369-80. PubMed ID: 25366362
[TBL] [Abstract][Full Text] [Related]
3. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.
Kribben A; Gerken G; Haag S; Herget-Rosenthal S; Treichel U; Betz C; Sarrazin C; Hoste E; Van Vlierberghe H; Escorsell A; Hafer C; Schreiner O; Galle PR; Mancini E; Caraceni P; Karvellas CJ; Salmhofer H; Knotek M; Ginès P; Kozik-Jaromin J; Rifai K;
Gastroenterology; 2012 Apr; 142(4):782-789.e3. PubMed ID: 22248661
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.
Hassanein TI; Tofteng F; Brown RS; McGuire B; Lynch P; Mehta R; Larsen FS; Gornbein J; Stange J; Blei AT
Hepatology; 2007 Dec; 46(6):1853-62. PubMed ID: 17975845
[TBL] [Abstract][Full Text] [Related]
5. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
6. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.
Saliba F; Camus C; Durand F; Mathurin P; Letierce A; Delafosse B; Barange K; Perrigault PF; Belnard M; Ichaï P; Samuel D
Ann Intern Med; 2013 Oct; 159(8):522-31. PubMed ID: 24126646
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.
Sen S; Davies NA; Mookerjee RP; Cheshire LM; Hodges SJ; Williams R; Jalan R
Liver Transpl; 2004 Sep; 10(9):1109-19. PubMed ID: 15350001
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
Donati G; La Manna G; Cianciolo G; Grandinetti V; Carretta E; Cappuccilli M; Panicali L; Iorio M; Piscaglia F; Bolondi L; Colì L; Stefoni S
Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy.
Camus C; Lavoué S; Gacouin A; Compagnon P; Boudjéma K; Jacquelinet C; Thomas R; Le Tulzo Y
Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480
[TBL] [Abstract][Full Text] [Related]
10. Albumin dialysis without anticoagulation in high-risk patients: an observational study.
Tan HK; Yang WS; Choong HL; Wong KS
Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517
[TBL] [Abstract][Full Text] [Related]
11. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
[TBL] [Abstract][Full Text] [Related]
12. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
Vaid A; Chweich H; Balk EM; Jaber BL
ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
[TBL] [Abstract][Full Text] [Related]
13. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
[TBL] [Abstract][Full Text] [Related]
15. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
16. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL
Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure.
Hessel FP; Bramlage P; Wasem J; Mitzner SR
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):213-20. PubMed ID: 19773666
[TBL] [Abstract][Full Text] [Related]
18. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure.
Novelli G; Rossi M; Ferretti G; Pugliese F; Travaglia D; Guidi S; Novelli S; Lai Q; Morabito V; Berloco PB
Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
Koivusalo AM; Kantola T; Arola J; Höckerstedt K; Kairaluoma P; Isoniemi H
Ther Apher Dial; 2009 Oct; 13(5):413-8. PubMed ID: 19788458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
